As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to EMA in 2018 about Draft Guideline: Responsibilities of the sponsor: Handling and shipping of investigational medicinal products for human use in accordance with Good Clinical Practice and Good Manufacturing Practice can be found below.